Home/Finvector Vision Therapies/Giuseppe Carloni

GC

Giuseppe Carloni

Chairman of the Board

Finvector Vision Therapies

Therapeutic Areas

Ophthalmology Oncology

Finvector Vision Therapies Pipeline

Drug	Indication	Phase
Non-Muscle Invasive Bladder Cancer Therapy (likely nadofaragene firadenovec/Adstiladrin)	Non-Muscle Invasive Bladder Cancer	Approved

Leadership Team at Finvector Vision Therapies

Vice Chair, Board Member

View full Finvector Vision Therapies profile